VolitionRx Limited appoints DXOCRO to undertake development and clinical validation studies for its Nu.Q product portfolio in the US
VolitionRx (NYSE-A:VNRX) Limited said it has appointed Diagnostic Oncology CRO, LLC (DXOCRO) to undertake development and clinical validation studies for...